NL-OMON40853已完成不适用
A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Migalastat Hydrochloride given Intravenously to Healthy Volunteers with an Open-Label, Randomized, Two-Way Crossover Arm - Migalastat hydrochloride SAD study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male and female subjects
- •- 18-45 yrs, inclusive
- •- BMI: 18.5-29.9 kg/m2, inclusive
- •- non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days prior to dosing day or being a blood donor (>500 mL) within 60 days from the start of the study.
研究者
相似试验
撤回
1 期
EmtinB Safety, Tolerability and Pharmacokinetics (PK) Study in Healthy Participantseurodegenerative disordersNeurodegenerative disordersNeurological - Neurodegenerative diseasesACTRN12622001019796euroScientific Biopharmaceuticals Ltd72
已完成
不适用
A Phase I, Randomized, Double-Blind, Placebo Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 986 in Healthy Subjects and Heart Failure Patientscardiac insufficiency10019280Heart failureNL-OMON46755Amgen4
尚未招募
1 期
A Study to Investigate the Safety of SEP-786 101 Capsules Compared With Placebo Capsules in Healthy Volunteer Participants Aged 24 Through 55 YearsHypoparathyroidismACTRN12624000898550Septerna, Inc.180
已完成
1 期
Assessment of the trial drugs ACH-0143102 and ACH-0142684, when taken by healthy men and women.ACTRN12614000102673Achillion Pharmaceuticals, Inc36
已完成
1 期
A Phase-I Clinical Trial to study the Safety and efficacy of Bharat Biotech International Limited Influenza A H1N1 pandemic 2009 Vaccine (Inactivated) in healthy volunteers.CTRI/2010/091/000152Bharat Biotech International Limited160